This playbook explains why medical treatments and interventions must be tested within the populations that require them.
Developing drugs and therapies that naturally have a direct impact on the health and well-being of its users means is there a scientific obligation to ensure validity. For example, the underrepresentation of communities in tested populations, as we have witnessed in recent years, contorts patient data, resulting in a failure to meet the scientific rigor a clinical trial must demand.
In this playbook, explore why representation must be improved in clinical trials, and why it is so crucial, including the following benefits:
Offered Free by: BioPharma Dive's studioID and WCG
See All Resources from: BioPharma Dive's studioID and WCG
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.